Cardiovascular Systems Inc. Watch

from 10-Q 27 pages Loan Agreement

from 10-Q 11 pages Second Amendment to Loan and Security Agreement

from 10-Q 10 pages First Amendment to Loan and Security Agreement

from 10-Q 46 pages Loan and Security Agreement

from 10-Q 4 pages Fifth Amendment to Loan and Security Agreement

from 10-K 4 pages Fourth Amendment to Loan and Security Agreement

from 10-K 7 pages Modification No. 4 to Loan and Security Agreement

from 10-K 10 pages Third Amendment to Loan and Security Agreement

from 10-K 10 pages Modification No. 3 to Loan and Security Agreement

from 10-K 14 pages Second Amendment to Loan and Security Agreement

from 10-Q 17 pages The Company Does Hereby Certify and Agree That, for the Sum of $1,271 Paid by Holder on the Date Hereof, Which the Parties Agree Is Fair Consideration for This Warrant, Holder, or Its Permitted Successors and Assigns, Hereby Is Entitled to Exercise or Exchange (Each as Defined Below) This Warrant in Cardiovascular Systems, Inc. (The “Company”) for Twenty-Three Thousand One Hundred Fifty-One (23,151) Duly Authorized, Validly Issued, Fully Paid and Non-Assessable Shares of Its Common Stock, $0.001 Par Value Each, Upon the Terms and Subject to the Provisions of This Warrant. the Shares of Common Stock Issuable Upon. Exercise or Exchange of This Warrant Are Referred to Herein as the “Warrant Stock”. Capitalized Terms Used but Not Defined in This Warrant Have Their Meanings as Set Forth in That Certain Loan and Security Agreement Between the Company and Holder Dated as of April 14, 2010, as Amended (The “Loan Agreement”). Section 1 Term, Price and Exercise or Exchange of Warrant. 1.1 Term of Warrant. This Warrant Shall Be Exercisable and Exchangeable for a Period of Five (5) Years From the Issue Date (Hereinafter Referred to as the “Expiration Date”)

from 10-Q 17 pages The Company Does Hereby Certify and Agree That, for the Sum of $186 Paid by Holder on the Date Hereof, Which the Parties Agree Is Fair Consideration for This Warrant, Holder, or Its Permitted Successors and Assigns, Hereby Is, Entitled to Exercise or Exchange (Each as Defined Below) This Warrant in Cardiovascular Systems, Inc. (The “Company”) for Three Thousand Three Hundred Ninety-Six (3,396) Duly Authorized, Validly Issued, Fully Paid and Non-Assessable Shares of Its Common Stock, $0.001 Par Value Each, Upon the Terms and Subject to the Provisions of This Warrant. the Shares of Common Stock Issuable Upon Exercise or Exchange of This Warrant Are Referred to Herein as the “Warrant Stock”. Capitalized Terms Used but Not Defined in This Warrant Have Their Meanings as Set Forth in That Certain Loan and Security Agreement Between the Company and Partners for Growth III, L.P. Dated as of April. 14, 2010, as Amended (The “Loan Agreement”). Section 1 Term, Price and Exercise or Exchange of Warrant. 1.1 Term of Warrant. This Warrant Shall Be Exercisable and Exchangeable for a Period of Five (5) Years From the Issue Date (Hereinafter Referred to as the “Expiration Date”)

from 10-Q 8 pages Modification No. 2 to Loan and Security Agreement

from 10-Q 18 pages The Company Does Hereby Certify and Agree That for Good and Valuable Consideration for This Warrant, Holder, or Its Permitted Successors and Assigns, Hereby Is Entitled to Exercise or Exchange (Each as Defined Below) This Warrant in Cardiovascular Systems, Inc. (The “Company”) for Twenty Four Thousand Nine Hundred (24,900) Duly Authorized, Validly Issued, Fully Paid and Non-Assessable Shares of Its Common Stock, $0.001 Par Value Each, Upon the Terms and Subject to the Provisions of This Warrant. the Shares of Common Stock Issuable Upon Exercise or Exchange of This Warrant Are Referred to Herein as the “Warrant Stock”. Capitalized Terms Used but Not Defined in This Warrant Have Their Meanings as Set Forth in That Certain Loan and Security Agreement Between the Company and Partners for Growth III, L.P. Dated as of April 14, 2010, as Amended (The “Loan Agreement”). Section 1 Term, Price and Exercise or Exchange of Warrant. 1.1 Term of Warrant. This Warrant Shall Be Exercisable and Exchangeable for a Period of Five (5) Years From the Issue Date (Hereinafter Referred to as the “Expiration Date”). 1.2 Exchange Price. the Price Per Share at Which the Warrant Stock Is Issuable Upon Exercise or Exchange of This Warrant Shall Be $9.33, Subject to Section 1.3 (A) Hereof and Subject to Adjustment From Time to Time as Set Forth Herein (The “Exchange Price”)

from 10-Q 17 pages First Amendment to Loan and Security Agreement

from 10-Q 5 pages Modification No. 1 to Loan and Security Agreement

from 10-Q 18 pages The Company Does Hereby Certify and Agree That, for the Sum of $3,007.76 Paid to Holder on the Date Hereof, Which the Parties Agree Is Fair Consideration for This Warrant, Holder, or Its Permitted Successors and Assigns, Hereby Is Entitled to Exchange This Warrant in Cardiovascular Systems, Inc. (The “Company”) for One Hundred Forty-Seven Thousand Three Hundred Thirty (147,330) Duly Authorized, Validly Issued, Fully Paid and Non-Assessable Shares of Its Common Stock, $0.001 Par Value Each, Upon the Terms and Subject to the Provisions of This Warrant. the Shares of Common Stock Issuable Upon Exchange of This Warrant Are Referred to Herein as the “Warrant Stock,” and the Warrant and the Warrant Stock Are Sometimes Together Referred to as the “Securities.” Capitalized Terms Used but Not Defined in This Warrant Have Their Meanings as Set Forth in That Certain Loan and Security Agreement of Even Date Herewith Between the Company and Holder (The “Loan Agreement”). Section 1 Term, Price and Exchange of Warrant. 1.1 Term of Warrant. This Warrant Shall Be Exchangeable for a Period of Five (5) Years From the Issue Date (Hereinafter Referred to as the “Expiration Date”)

from 10-Q 31 pages Loan and Security Agreement

from 10-Q 38 pages Loan and Security Agreement

from 10-Q 8 pages Assumption Agreement and First Amendment to Loan and Security Agreement